CClinicalTrials.gg
CompletedNCT03440047Updated Oct 3, 2023Results posted

Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim

An interventional study of Fuji Flim Processor VP-7000, Light Source BL-7000 in Gastro-Intestinal Disorder, sponsored by Mayo Clinic. Completed at 2 sites in United States. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2023-10-03.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
355
Allocation
Not applicable
Ages
18 Years to 100 Years
Sex
All
01

Study summary

The purpose of this study is to see if advanced endoscopic imaging may be helpful to accurately distinguish pathological tissue from normal tissue and guide therapy of endoscopically identified pathology.

Read the detailed description

In this registry, the Fujifilm 4-LED system, which is considered non significant risk, will be used for routine endoscopic procedures at Mayo Clinic Florida and Rochester. Where indicated and based on clinical standards of care, a biopsy or tissue removal will be performed. Immediately prior to tissue removal, a standard set of electronic images will be captured including white light, BLI, BLI-bright, LCI. Each image will be stored in high resolution lossless format and later correlated with the final clinical and histological diagnosis.

02

Conditions studied

  • Gastro-Intestinal Disorder

Keywords

  • endoscopic image
  • Fujifilm
  • Blue light imaging
03

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. All patients age 18-100 undergoing planned upper or lower endoscopy at Mayo Clinic Rochester
  2. Informed Consent

Exclusion criteria

Exclusion Criteria:

  1. Patient unwilling to provide informed consent
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
355 participants (actual)

Study arms

  • Experimental
    Fuji Flim Processor VP-7000

    Screening or surveillance colonoscopy using Fuji Flim Processor VP-7000, Light Source BL-7000

    Device: Fuji Flim Processor VP-7000, Light Source BL-7000

Interventions

  • DeviceFuji Flim Processor VP-7000, Light Source BL-7000

    Fujifilm's Digital Video Processor VP-7000 and LED Light Source BL-7000 is a class II Endoscopic Video Imaging System under 21 C.F.R. 876.1500. It is the next generation of Fujifilm's VP-4440HD Digital Video Processor with Flexible-spectral Imaging Color Enhancement (FICE) and Light Source (K140149).

05

What researchers measure

Primary outcomes

  1. Number of Subjects Whose Endoscopic Images Correlated With Final Clinical and Histological Diagnosis

    Subjects presenting with gastrointestinal mucosal disorders will have a biopsy based on clinical standard of care. Just prior to the biopsy, a standard set of electronic images will be captured using the Fujifilm 7000 Blue Light Imaging System with 4-LED Multi Light Technology. Images will be correlated with the final clinical and histological diagnosis of the gastrointestinal disorder.

    Time frame: Approximately one year

06

Results

Posted Oct 3, 2023

Participant flow

Participant flow — Overall Study
MilestoneFuji Film Processor VP-7000
Started355
Completed353
Not completed2
Withdrew: Withdrawal by subject2

Outcome measures

PrimaryNumber of Subjects Whose Endoscopic Images Correlated With Final Clinical and Histological Diagnosis

Subjects presenting with gastrointestinal mucosal disorders will have a biopsy based on clinical standard of care. Just prior to the biopsy, a standard set of electronic images will be captured using the Fujifilm 7000 Blue Light Imaging System with 4-LED Multi Light Technology. Images will be correlated with the final clinical and histological diagnosis of the gastrointestinal disorder.

Time frame:
Approximately one year
Reported as:
Number · participants
Number of Subjects Whose Endoscopic Images Correlated With Final Clinical and Histological Diagnosis
participantsFuji Film Processor VP-7000
Number of Subjects Whose Endoscopic Images Correlated With Final Clinical and Histological Diagnosis283

Adverse events

Collected over Adverse event data collected from endoscopy to either clinical or pathological results return, up to one year.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Fuji Film Processor VP-70000/355 (0%)4/355 (1.1%)13/355 (3.7%)
Most frequent serious events
Most frequent serious events
EventFuji Film Processor VP-7000
Abdominal painGastrointestinal disorders1/355
StrokeVascular disorders1/355
Esophageal PerforationGastrointestinal disorders1/355
Gastrointestinal BleedGastrointestinal disorders1/355
Gastric ulcersGastrointestinal disorders1/355
HematemesisGastrointestinal disorders1/355
Most frequent other events
Showing 10 of 11
Most frequent other events
EventFuji Film Processor VP-7000
COVID-19Infections and infestations2/355
VomitingGastrointestinal disorders2/355
Tooth extractionSurgical and medical procedures1/355
Perirectal abscessGastrointestinal disorders1/355
Back painMusculoskeletal and connective tissue disorders1/355
VasculitisVascular disorders1/355
Head injuryInjury, poisoning and procedural complications1/355
Fall secondary to syncopeInjury, poisoning and procedural complications1/355
Opioid overdoseInjury, poisoning and procedural complications1/355
HyperglycemiaEndocrine disorders1/355

Baseline characteristics

Age, Continuous
Age, Continuous(years)Fuji Film Processor VP-7000
Mean59.7 (20 to 90)
Sex: Female, Male
Sex: Female, Male(Participants)Fuji Film Processor VP-7000
Female154
Male201
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Fuji Film Processor VP-7000
Hispanic or Latino14
Not Hispanic or Latino336
Unknown or Not Reported5
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Fuji Film Processor VP-7000
American Indian or Alaska Native0
Asian6
Native Hawaiian or Other Pacific Islander1
Black or African American14
White325
More than one race2
Unknown or Not Reported7
Region of Enrollment
Region of Enrollment(Participants)Fuji Film Processor VP-7000
United States355
07

Study locations

2 sites
  • Mayo Clinic in Florida
    Jacksonville, Florida 32224, United States
  • Mayo Clinic in Rochester
    Rochester, Minnesota 55905, United States
08

References and documents

Study documents

  • Study protocol · Jul 15, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03440047
Lead sponsor
Mayo Clinic
Collaborators
Fujifilm Medical Systems USA, Inc.
Responsible party
Nayantara Coelho-Prabhu (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Feb 20, 2018
Start date
Aug 28, 2017
Primary completion
Dec 5, 2022
Completion
Mar 1, 2023
Results posted
Oct 3, 2023
Last update
Oct 3, 2023

Study contacts

Nayantara Coelho-Prabhu, MBBS
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion